FDA To Create Inter-Center Advertising Policy Group
Executive Summary
FDA is forming an inter-center group to oversee advertising policies for different products regulated by the agency, Acting Commissioner Lester Crawford announced at a recent National Press Club luncheon in Washington, D.C
You may also be interested in...
FDA Chief Counsel Warning Letter Review To Continue After Troy’s Departure
The FDA Office of Chief Counsel's review of warning and untitled letters has resulted in the rejection of approximately 5% of letters, outgoing Chief Counsel Daniel Troy said
FDA Cites J&J Duragesic Promotion For Using Post-Market Abuse Data
FDA has issued a warning letter to Janssen for a Duragesic promotion containing comparative data versus other pain agents on post-marketing reports of abuse
FDA Cites J&J Duragesic Promotion For Using Post-Market Abuse Data
FDA has issued a warning letter to Janssen for a Duragesic promotion containing comparative data versus other pain agents on post-marketing reports of abuse